Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCTV01E Booster in mRNA-Vaccinated Adults
NCT05329051Phase 2Unknown
- Sponsor
- Sinocelltech Group Limited
- Start
- Jul 2022
- Primary completion
- Sep 2022
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of SCTV01E in coronavirus disease 2019 (COVID-19), sponsored by Sinocelltech Group Limited. Status: unknown.
02
Drugs
SCTV01E
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05329051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05329051.